Life insurance urine tests screen for two broad categories: drug use and hidden health problems. The sample you provide during a life insurance medical exam gets checked for nicotine, illegal drugs, prescription drug misuse, and several markers of kidney disease, diabetes, and heart failure. The results directly affect whether you’re approved and how much you’ll pay.
Nicotine and Tobacco Use
Tobacco status is one of the single biggest factors in life insurance pricing, and the urine test is how insurers verify what you reported on your application. The test measures cotinine, a chemical your body produces when it breaks down nicotine. Cotinine stays in your system much longer than nicotine itself, making it harder to game by quitting for a few days before the exam.
Urine cotinine cutoff values used to classify someone as a smoker typically fall between 50 and 200 ng/mL, though some studies support lower thresholds. If your cotinine comes back above the insurer’s cutoff, you’ll be rated as a tobacco user regardless of what you wrote on your application. That classification can double or even triple your premiums. This includes cigarettes, cigars, chewing tobacco, vaping, and nicotine patches or gum.
Illegal and Prescription Drugs
The standard drug panel covers a wide range of substances. Expect screening for:
- Cocaine
- Amphetamines and methamphetamines
- Opiates, including codeine, morphine, hydrocodone, oxycodone, fentanyl, and heroin
- Benzodiazepines (anti-anxiety medications like Xanax and Valium)
- Barbiturates
- Methadone
- PCP
- Marijuana (THC)
A positive result for cocaine, methamphetamine, PCP, or heroin will almost certainly result in a denial. Prescription medications like opioids or benzodiazepines won’t automatically disqualify you if you have a valid prescription and disclosed the medication on your application. The concern is undisclosed use or patterns suggesting misuse.
Marijuana is a gray area. Even in states where recreational use is legal, many insurers still test for THC and may rate you higher or decline coverage based on a positive result. Some carriers have become more lenient in recent years, treating occasional marijuana use similarly to moderate alcohol consumption, but policies vary widely.
Kidney Disease Markers
One of the most important things insurers look for in urine has nothing to do with drugs. It’s protein, specifically albumin, which is the main protein in your blood. Healthy kidneys filter waste out of the blood while keeping albumin in. When kidney filters are damaged by conditions like high blood pressure or diabetes, albumin leaks into the urine.
Even small amounts of albumin in the urine (a condition called microalbuminuria) signal elevated risk. According to data from Clinical Reference Laboratory, applicants whose albumin-to-creatinine ratio fell in the highest 5% for their age and sex had a mortality rate more than four times higher than those in the lowest quartile. That’s a powerful predictor, which is why insurers pay close attention to it.
The test also measures creatinine, a waste product from muscle metabolism. Creatinine itself isn’t the concern. It’s used as a reference point to adjust for how concentrated or diluted your sample is. A dehydrated person will have higher raw protein readings than someone who drank a lot of water, so dividing protein by creatinine removes that variability and gives a more accurate picture.
Diabetes Indicators
Your urine gets checked for glucose and for a marker called hemoglobin A1c (HbA1c). Glucose in the urine typically means blood sugar levels have been running high enough for the kidneys to start spilling sugar they’d normally reabsorb. That’s a red flag for undiagnosed or poorly controlled diabetes.
HbA1c reflects your average blood sugar over the previous two to three months, so it can’t be lowered by eating well for a week before the exam. Microalbumin, the kidney protein marker mentioned above, also doubles as a diabetes indicator because diabetes is one of the leading causes of kidney damage. Together, these markers give underwriters a reliable snapshot of your metabolic health.
Heart and Prostate Screening
Some insurers include a test for NT-proBNP, a protein released by the heart when it’s under strain. Elevated levels can indicate congestive heart failure, sometimes before a person has noticeable symptoms. For male applicants, PSA (prostate-specific antigen) may be included to flag potential prostate issues. These tests are more common in expanded panels used for higher coverage amounts or older applicants.
Cystatin C for Overall Risk
A newer addition to some insurance panels is cystatin C, a small protein that serves as a sensitive marker for kidney function and overall mortality risk. It can detect early kidney decline that traditional tests miss, giving underwriters another data point for assessing long-term health.
Sample Validity Checks
Before any of the above gets analyzed, the lab checks whether your sample is actually usable. Specific gravity measures how concentrated the urine is, with a normal range of about 1.005 to 1.030. A sample that falls below this range is considered overly diluted, which could mean you overhydrated before the test or, in rarer cases, attempted to flush out detectable substances. A diluted sample typically means you’ll be asked to retake the test.
Common Causes of False Positives
Insurance urine tests use immunoassay screening, a method that’s fast and cost-effective but not perfect. Certain everyday medications can trigger false positive results for substances you’ve never taken.
Pseudoephedrine and phentermine (a weight loss medication) can flag as amphetamines. The cough suppressant dextromethorphan, found in many over-the-counter cold medicines, can produce false positives for both opioids and PCP. Ibuprofen and naproxen have been known to trigger false results for barbiturates and even cannabinoids. The allergy medication diphenhydramine (Benadryl) can falsely flag for opioids, PCP, or methadone. Even poppy seeds remain a real cause of false opioid positives.
The antidepressant bupropion can trigger a false positive for amphetamines or PCP. Sertraline (Zoloft) has been linked to false benzodiazepine results. And the antipsychotic quetiapine can falsely register as methadone.
If you’re taking any of these medications, mention them when scheduling your exam. A positive screening result will usually be sent for confirmatory testing using a more precise method that can distinguish the actual substance present. This follow-up testing eliminates most false positives, but the process can delay your application by several weeks. Disclosing your medications upfront speeds things along.
How Results Affect Your Policy
Underwriters use urine test results alongside your blood work, medical records, and application answers to assign you a risk class. Clean results with no health flags typically qualify you for preferred or standard rates. Elevated protein, signs of uncontrolled diabetes, or a positive nicotine result will push you into higher-rate categories. A positive result for hard drugs like cocaine or methamphetamine usually means an outright decline, with most insurers requiring you to wait at least one to two years before reapplying.
The urine test captures a narrower window than blood work for most substances, generally reflecting the past few days to a few weeks depending on the drug. But the health markers, particularly HbA1c and albumin, reflect months of metabolic history. There’s no realistic way to prepare for those other than genuinely managing your health over time.